Braving the Storm for LBCT Selection
ACC.11 and i2 Summit 2011 meeting co-chairs are at Heart House today (or at least some of them are ... DC got quite the snow storm last night and not all could make it in) to discuss details about our upcoming meeting in New Orleans, April 2-5. The meeting co-chairs will be discussing the LBCT submissions and making decisions about what science will, and won’t, make the cut for presentation. Selected LBCTs represent the best of the best: the studies most likely to completely alter clinical practice. The submitted trials are judged on the impact and novelty of their research; rigor of the design/methods; major clinical endpoints; and the quality of the statistical plan.
In addition to presenting their trial, presenters also participate in an unstructured Q & A session called “The Trialist Is In.” These informal sessions are designed to foster greater interaction between participants and trialists. The Trialist Is In sessions at ACC.10 were popular, well-attended and a marvelous opportunity to “touch the sleeve of the master.”
Finally, a plug for how to stay in touch between now and April: Join the ACC.11 & i2 Summit Community on CardioSource. The community is meant as a space to discuss the science, connect with other attendees, and hear from the meeting co-chairs and other faculty. You can start by introducing yourself in the Introductions forum! Also, follow @ACC_11 on Twitter for updates if you’re on Twitter.
< Back to Listings